A study investigating IFNγ effects on NK-mediated lysis in 22 pediatric tumor cell lines, including NB, revealed varied responses to treatment, with some NB lines remaining unaffected, some developing resistance, and others becoming more sensitive [83]. The gene discussed is IFNG; the disease is neuroblastoma.